SCFA-GPR41 and GPR43 interactions trigger the expression of leptin from adipocytes and impact the inflammatory responses that are severe for the development of obesity-related metabolic disorders such as insulin resistance, lipogenesis, and increased triglyceride stores. Here, INS is linked to obesity disorder.